Determining Potential Risk Factors for Epilepsy in Children with Neonatal Hypoglycemia

Shima Hosseinzadeh1, Dorsa Vagharmousavi1, Rezvan Rajabzadeh2

  • 1School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.

PubMed

Insights

Neonatal hypoglycemia increases epilepsy risk in children, especially with NICU stays or family history. Early detection and intervention are crucial for preventing neurological complications.

Area of Science:

  • Pediatrics
  • Neurology
  • Neonatology

Background:

  • Neonatal hypoglycemia poses risks for neurological complications.
  • Identifying risk factors for epilepsy in children with a history of neonatal hypoglycemia is essential.

Purpose of the Study:

  • To investigate risk factors for epilepsy in children with a history of neonatal hypoglycemia in North Khorasan Province.

Main Methods:

  • A case-control study involving 64 children with a history of neonatal hypoglycemia.
  • Data collected included medical records, MRI, Ages and Stages Questionnaire (ASQ), and pregnancy/delivery/neonatal information.
  • Statistical analysis performed using SPSS v20.

Main Results:

  • Epilepsy was associated with familial history (p<0.05), extended hypoglycemia duration, and NICU stays (p<0.05).
  • Delayed onset of hypoglycemia significantly increased epilepsy risk (8x higher risk per extra day).
  • ASQ revealed significant developmental deficiencies in the epilepsy group; MRI showed abnormalities like gliosis and encephalomalacia in 82% of epilepsy cases.

Conclusions:

  • Neonatal hypoglycemia is a significant risk factor for childhood epilepsy.
  • Extended NICU stays, delayed hypoglycemia onset, and family history elevate this risk.
  • Prompt identification and intervention for at-risk newborns are vital to mitigate epilepsy and neurodevelopmental issues.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
280
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
589
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
335
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
243
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
448